Activity ID



December 7, 2019

Format Type


CME Credit



CME Provider

University of South Florida Health


Pain continues to be a significant public-health problem in the US, causing significant reductions in patients’ quality of life. Despite the pain-relieving properties of opioid medications, patients with acute and chronic pain are often undertreated due to a variety of physician- and patient-related concerns and barriers, including the potential for misuse and abuse.

The Food and Drug Administration (FDA) developed the Risk Evaluation and Mitigation Strategy (REMS) to ensure the benefits outweigh the risks with opioid treatments. The FDA Blueprint was recently updated to include more information on pain management, including components of an effective treatment plan,
nonpharmacologic and pharmacologic treatments for pain (nonopioid and opioid analgesics), and a primer on addiction medicine. The updated blueprint applies not only to prescribers, but to all healthcare providers involved in the management of patients with acute and chronic pain.

Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS) incorporates the updated FDA blueprint into practical education designed to help clinicians improve the quality of care and reduce the pain of their patients.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

-Identify risk factors and vulnerabilities associated with addiction to opioid analgesics and provide patient/caregiver counselling when necessary
-Discuss the components of an effective treatment plan, including patient interactions, treatment goals, and collaboration within the healthcare team
-Analyze the specific benefits and risks to initiating non-medication therapies before utilizing long-term medications
-Recognize patients who are candidates for treatment with nonopioid pharmacologic analgesics
-Explain the decision to initiate long-term opioid analgesics, including ER/LA opioids, with consideration to providing in-home naloxone
-Determine when referral to a pain specialist is appropriate for a patient with chronic pain


Opioid therapy, Pain management, Substance use disorder, Multimodal


Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement, Systems-based Practice

CME Credit Type

AAFP Prescribed Credit, AMA PRA Category 1 Credit

Opioid REMS

This educational activity is supported by an independent educational grant from the Extended-Release/Long-Acting Opioid Analgesic REMS Program Companies.

Practice Setting

Outpatient, Physician Scientists, Rural, Urban

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.